689
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Reply to letter by Hadigal et al. regarding the cost-effectiveness of high dose quadrivalent vaccine in three European countries

, , , , , , & show all
Pages 1167-1168 | Received 16 Jun 2023, Accepted 05 Jul 2023, Published online: 17 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.